Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
Inovio Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: March 25, 2021
Inovio Pharmaceuticals reported fiscal year 2020 executive compensation information on March 25, 2021.
In 2020, four executives at Inovio Pharmaceuticals received on average a compensation package of $2.8M, a 90% increase compared to previous year.
Average pay of disclosed executives at Inovio Pharmaceuticals
J. Joseph Kim, Chief Executive Officer, received $4.7M in total, which increased by 82% compared to 2019. 74% of Kim's compensation, or $3.5M, was in stock awards. Kim also received $500K in non-equity incentive plan, $695K in salary, as well as $13K in other compensation.
For fiscal year 2020, the median employee pay was $185,948 at Inovio Pharmaceuticals. Therefore, the ratio of J. Joseph Kim's pay to the median employee pay was 25 to one.
Peter D. Kies, Chief Financial Officer, received a compensation package of $2.2M, which increased by 88% compared to previous year. 70% of the compensation package, or $1.5M, was in stock awards.
Laurent M. Humeau, Chief Scientific Officer, earned $2.1M in 2020, a 120% increase compared to previous year.
Jacqueline E. Shea, Chief Operating Officer, received $2.1M in 2020, which increases by 85% compared to 2019.
Related executives
You may also like
Source: SEC filing on March 25, 2021.